AFT Pharmaceuticals Limited reported earnings results for the half year ended September 30, 2022. For the half year, the company reported sales was NZD 65.75 million compared to NZD 55.51 million a year ago. Net income was NZD 1.45 million compared to NZD 4.24 million a year ago.

Basic earnings per share from continuing operations was NZD 0.01 compared to NZD 0.04 a year ago.